Structural Heart and Valve Disease

Beaumont’s structural heart and heart valve program offers the most advanced approaches for treating structural heart disorders. Our multidisciplinary team is committed to evaluating patients with complex structural heart disease and high-risk patients with valvular disease, and developing individualized treatment plans to ensure the best outcome for you.

Unlike coronary artery disease, structural heart disease doesn’t typically affect the blood vessels that supply the heart muscle with blood and oxygen. Rather, structural cardiac defects may be present at birth (congenital) or form later in life because of infection, wear and tear from aging, or underlying disease processes.

Beaumont’s heart team is pioneering innovative research and developing the latest techniques for patients to receive the safest and most effective treatments.

  • Most of our aortic and mitral valve replacements are done through minimally invasive techniques instead of a sternotomy/open-heart procedure
  • We were the first hospital in Michigan and the Midwest to implant the commercially approved WATCHMAN left atrial appendage closure device in 2015
  • Beaumont was the first hospital in Michigan to implant the commercially approved MitraClip in 2013
  • We were the first hospital in the United States to replace an aortic valve with a catheter in 2005
  • Advancing the care for our patients through participation in the most recent clinical trials including MitraClip trial research results

Common Heart Valve and Structural Heart Conditions

Common Heart Valve and Structural Heart Treatment Options

  • Medical: In certain situations, some patient’s heart conditions can be controlled with medication.  The symptoms associated with structural heart or valve disease may lessen with medications and it is possible certain medications may control irregular heartbeats, increase the heart’s ability to pump and relieve discomfort.  Contact your physician to determine the best treatment plan for you and your conditions.
    • Percutaneous or transcatheter treatment: Transcatheter procedures such as TAVR, TMVR, Watchman or MitraClip are performed by our skilled heart team physicians in our state-of the-art catheterization lab or Tyner Center for Cardiovascular Interventions center hybrid surgical suite.  These procedures are designed for patients that are too high-risk for traditional surgical procedures and provides our patients an alternative less invasive treatment option to repair or replace valves or other congenital heart disorders.
  • Surgical treatment: Our cardiac surgeons are experts at minimally invasive surgical techniques for heart valve and congenital heart disease which involves smaller incisions and quicker recovery time. On some occasions, the cardiac surgeon may recommend a full sternotomy or open-heart procedure.